Arnold J Levine Selected Research

Arnold J Levine Research Topics

Disease

64	Neoplasms (Cancer) 03/2024 - 07/2002
6	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2009
6	Carcinogenesis 05/2013 - 06/2004
3	Communicable Diseases (Infectious Diseases) 01/2020 - 10/2010
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2016 - 02/2010
2	Adenocarcinoma of Lung 01/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 05/2016 - 03/2003
2	Lymphoma (Lymphomas) 12/2014 - 01/2005
2	Prostatic Neoplasms (Prostate Cancer) 09/2012 - 12/2011
2	Retinoblastoma (Glioblastoma, Retinal) 09/2012 - 02/2009
2	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2007 - 10/2005
2	Starvation 04/2007 - 06/2005
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2004 - 06/2004
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Carcinoma (Carcinomatosis) 11/2021
1	Colitis 01/2019
1	Herpesviridae Infections (Herpesvirus Infection) 01/2019
1	Adenocarcinoma 03/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017
1	Teratocarcinoma 01/2016
1	Heart Diseases (Heart Disease) 01/2012
1	Gallstones (Gallstone) 01/2012
1	Ductal Carcinoma 02/2011
1	Hypoxia (Hypoxemia) 10/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2010
1	Colorectal Neoplasms (Colorectal Cancer) 02/2010
1	Carcinoid Tumor (Carcinoid) 02/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2010

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2003
9	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 04/2008
6	Transcription Factors (Transcription Factor)IBA 10/2021 - 10/2010
5	AntigensIBA 01/2021 - 11/2017
4	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2009
4	Messenger RNA (mRNA)IBA 01/2019 - 12/2003
3	Peptides (Polypeptides)IBA 12/2023 - 11/2017
3	Phenobarbital (Luminal)FDA Link 01/2019 - 11/2007
3	Estrogen ReceptorsIBA 04/2011 - 11/2009
3	Glucose (Dextrose)FDA LinkGeneric 12/2010 - 06/2005
2	Bispecific AntibodiesIBA 01/2021 - 10/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 02/2009
2	Codon (Codons)IBA 01/2018 - 01/2014
2	MetallochaperonesIBA 10/2016 - 11/2015
2	ZincIBA 10/2016 - 11/2015
2	Phosphotransferases (Kinase)IBA 09/2012 - 10/2007
2	Tumor Suppressor Protein p53IBA 05/2012 - 07/2005
2	Indicators and Reagents (Reagents)IBA 12/2011 - 02/2010
2	MicroRNAs (MicroRNA)IBA 06/2010 - 04/2010
2	NF-kappa B (NF-kB)IBA 08/2004 - 06/2004
1	Proline (L-Proline)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	tumor-associated transplantation antigen (TSTA)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	DNA Transposable Elements (Element, IS)IBA 01/2019
1	Mutant Proteins (Protein, Mutant)IBA 01/2018
1	MutagensIBA 01/2018
1	CytosineIBA 01/2018
1	NucleotidesIBA 01/2018
1	EpitopesIBA 11/2017
1	Complement C5a (Complement 5a)IBA 05/2016
1	Complement C5 (Complement 5)IBA 05/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Pattern Recognition ReceptorsIBA 12/2015
1	Proteasome InhibitorsIBA 07/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2015
1	Bortezomib (Velcade)FDA Link 07/2015
1	Hypoxia-Inducible Factor 1IBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	CyclinsIBA 12/2014
1	ProteomeIBA 01/2014
1	DipeptidesIBA 01/2014
1	Amino Acids FDA Link 01/2014
1	Monoclonal AntibodiesIBA 10/2012
1	Protein Isoforms (Isoforms)IBA 09/2012
1	VimentinIBA 09/2012
1	palbociclibIBA 09/2012
1	Cyclin D1IBA 09/2012
1	SterolsIBA 01/2012
1	Mevalonic Acid (Mevalonate)IBA 01/2012
1	Tamoxifen FDA LinkGeneric 01/2012
1	CholesterolIBA 01/2012
1	AntioxidantsIBA 09/2011
1	Leukemia Inhibitory FactorIBA 07/2011
1	ElementsIBA 02/2011
1	Adenosine Triphosphate (ATP)IBA 12/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2010
1	Carbon DioxideIBA 12/2010
1	CytokinesIBA 10/2010
1	3' Untranslated Regions (3' UTR)IBA 04/2010
1	AntibodiesIBA 02/2010
1	Genetic Markers (Genetic Marker)IBA 01/2010
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2009
1	Adenovirus E1A Proteins (Adenovirus E1A Protein)IBA 02/2009

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2002
5	Immunotherapy 03/2024 - 03/2018
2	Drug Therapy (Chemotherapy) 03/2018 - 07/2015
1	Molecular Targeted Therapy 10/2012